Company intelligence / Profile preview

Fenwal International

Lake Zurich, Illinois, United States

Ownership: Private
Employees: ~2000
Development stage: Other

Overview

Fenwal is a global medical technology company specializing in products and services for blood collection, separation, and transfusion medicine. Originally a division of Baxter International, the company became an independent entity in 2007 before being acquired by Fresenius Kabi in 2012. Fenwal's portfolio includes automated apheresis systems, manual blood collection sets, and advanced filtration technologies used by blood centers and hospitals worldwide. Their flagship products, such as the Amicus and Alyx systems, are industry standards for collecting platelets, plasma, and red blood cells to support critical healthcare needs.

Therapeutic areas: Hematology
Modalities: Device
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Fenwal International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fenwal International.

Explore the full profile